Cumambrin A prevents OVX‐induced osteoporosis via the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathways
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lewellen T. K., 1977, Absolute measurement of total-body calcium by the Ar-37 method-preliminary results: concise communication, J. Nucl. Med., 18, 929
Rular J., 2012, An overview of the regulation of bone remodelling at the cellular level, Clin. Biochem., 45, 863, 10.1016/j.clinbiochem.2012.03.021
Blair H. C., 2004, Recent advances in osteoclast biology and pathological bone resorption, Histol. Histopathol., 19, 189
Takayanagi H., 2009, [Molecular determinants in osteoclast differentiation and osteoimmunology], Rinsho Ketsueki, 50, 447
Schmidt T. J., 1999, Toxic activities of sesquiterpene lactones: structural and biochemical aspects, Curr. Org. Chem., 3, 577
Tarasov V. A., 1974, Cumambrin A—a sesquiterpene lactone from Handelia trichophylla, Chem. Nat. Compd., 10, 10.1007/BF00564023
Jiang M., 2011, The role of Chinese medicine in the treatment of chronic diseases in China, Planta Med., 77, 873, 10.1055/s-0030-1270983
Soysa N. S., 2012, Osteoclast formation and differentiation: an overview, J. Med. Dent. Sci., 59, 65
Brown K. D., 2008, The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis, Arthritis Res. Ther., 10, 10.1186/ar2457
Jee W. S., 2001, Overview: animal models of osteopenia and osteoporosis, J. Musculoskelet. Neuronal Interact., 1, 193